Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina
Diego Ojeda, María Mora Gonzalez Lopez Ledesma, Horacio M. Pallarés, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009161-e1009161
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
Andrés H. Rossi, Diego Ojeda, Augusto Varese, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 8, pp. 100359-100359
Open Access | Times Cited: 83
SARS-CoV-2 infection negatively affects ovarian function in ART patients
Yamila Herrero, Natalia Pascuali, Candela Velázquez, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 1, pp. 166295-166295
Open Access | Times Cited: 69
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
Alessandra Aiello, Saeid Najafi Fard, Elisa Petruccioli, et al.
International Journal of Infectious Diseases (2021) Vol. 106, pp. 338-347
Open Access | Times Cited: 50
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2
María Noel Badano, Florencia Sabbione, Irene Keitelman, et al.
Molecular Immunology (2022) Vol. 143, pp. 94-99
Open Access | Times Cited: 32
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273
Carla A. Pascuale, Augusto Varese, Diego Ojeda, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 8, pp. 100706-100706
Open Access | Times Cited: 31
Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time
María Mora González López Ledesma, Lautaro Sánchez, Diego Ojeda, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Endemic coronavirus in children and adults with acute respiratory infection before the COVID-19 pandemic
Raquel Jara, Denize Palmito dos Santos, Noelia Reyes, et al.
Revista Argentina de Microbiología (2025)
Open Access
Immunological memory to COVID-19 vaccines in immunocompromised and immunocompetent children
Constanza Russo, Adrián Otero, Macarena Uranga, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers
Vanesa Seery, Silvina Raiden, Silvia Algieri, et al.
EBioMedicine (2021) Vol. 67, pp. 103357-103357
Open Access | Times Cited: 35
Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms
Mahender Aileni, Gulab Khan Rohela, Phanikanth Jogam, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1182-1182
Open Access | Times Cited: 22
Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019
Ignacio Mazzitelli, Lucia Bleichmar, María Guillermina Ludueña, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 4, pp. 575-585
Open Access | Times Cited: 28
A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children
Inés Sananez, Silvina Raiden, Silvia Algieri, et al.
EBioMedicine (2021) Vol. 72, pp. 103615-103615
Open Access | Times Cited: 23
COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity
Lorenzo Erra, Ignacio Uriarte, Ana Colado, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 2, pp. 271-285
Open Access | Times Cited: 18
Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study
Vanesa Seery, Silvina Raiden, Constanza Russo, et al.
EBioMedicine (2022) Vol. 83, pp. 104230-104230
Open Access | Times Cited: 16
ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors
Andrea Estefanía Portales, Emilio Román Mustafá, Clara Inés McCarthy, et al.
Life Sciences (2022) Vol. 293, pp. 120284-120284
Open Access | Times Cited: 15
Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Nana Owusu‐Boaitey, Timothy Russell, Gideon Meyerowitz‐Katz, et al.
Eurosurveillance (2023) Vol. 28, Iss. 21
Open Access | Times Cited: 8
Performance assessment of seven SARS‐CoV‐2 IgG enzyme‐linked immunosorbent assays
Ketki Deshpande, Ullas PT, Ojas Kaduskar, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6696-6702
Open Access | Times Cited: 18
Antibody durability at 1 year after Sputnik V vaccination
Lautaro Sánchez, Santiago Oviedo Rouco, Marina Pífano, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 5, pp. 589-590
Open Access | Times Cited: 13
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people
Santiago Oviedo Rouco, Pamela Elizabeth Rodríguez, Esteban A. Miglietta, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 8, pp. 1118-1119
Open Access | Times Cited: 12
Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19
Luciana Villafañe, Lucía Gallo Vaulet, Florencia M. Viere, et al.
Journal of Immunological Methods (2021) Vol. 500, pp. 113182-113182
Open Access | Times Cited: 15
Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires
Andrea Pécora, D.A. Malacari, Marina Mozgovoj, et al.
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 9
SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants
Yésica Longueira, Diego Ojeda, Rocio B. Antivero Battistelli, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Immunogenicity induced by the use of alternative vaccine platforms to deal with vaccine shortages in a low- to middle-income country: Results of two randomized clinical trials
Alejandro Macchia, Daniel Ferrante, María Belén Bouzas, et al.
The Lancet Regional Health - Americas (2022) Vol. 9, pp. 100196-100196
Open Access | Times Cited: 8
A review on biotechnologically derived techniques to combat COVID-19 situation
Akanksha Jain, Sonia Bajaj, Parag Jain, et al.
Health Sciences Review (2023) Vol. 8, pp. 100112-100112
Open Access | Times Cited: 4
Facing up to the COVID-19 pandemic in Argentina
Gabriel A. Rabinovich, Jorge Geffner
Nature Immunology (2021) Vol. 22, Iss. 3, pp. 264-265
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top